This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.
Diabetes technology & therapeutics · 2026
Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.
Diabetes technology & therapeutics · 2026
Artificial Intelligence-Based Digital Biomarkers for Type 2 Diabetes: A Review.
The Canadian journal of cardiology · 2024
Latest funding
- $1,005,976
Steatotic Liver Disease, Fibrosis and Inflammatory Bowel Disease: Uncovering the Triple Threat
CIHR · 2026 · Co-investigator
- $91,800
Comparative Efficacy and Safety of GLP-1 Receptor Agonists and Co-Agonists for Weight Loss Among Adults with Overweight or Obesity without Diabetes: A Systematic Review and Network Meta-Analysis
CIHR · 2026 · Co-investigator
- $703,800
Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program
CIHR · 2025 · Principal investigator
7 publications.
Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.
Sabelli N, Pasqua MR, Perz N, Majdpour D, Tsoukas M, Haidar A
Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and Exercise.
Lawton E, Perz L, Pasqua MR, Tsoukas M, Haidar A
Artificial Intelligence-Based Digital Biomarkers for Type 2 Diabetes: A Review.
Jabara M, Kose O, Perlman G, Corcos S, Pelletier MA, Possik E, Tsoukas M, Sharma A
Synchronous Health Care Delivery for the Optimization of Cardiovascular and Renal Care in Patients with Type 2 Diabetes.
Alqahtani M, Ganni E, Mavrakanas T, Tsoukas M, Peters T, Suri R, Fantus IG, Pavilanis A, Guida J, Razaghizad A, Sharma A
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Razaghizad A, Oulousian E, Randhawa VK, Ferreira JP, Brophy JM, Greene SJ, Guida J, Felker GM, Fudim M, Tsoukas M, Peters TM, Mavrakanas TA, Giannetti N, Ezekowitz J, Sharma A
Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies.
Gouda P, Zheng S, Peters T, Fudim M, Randhawa VK, Ezekowitz J, Mavrakanas TA, Giannetti N, Tsoukas M, Lopes R, Sharma A
Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.
Tsoukas M, Rutkowski J, El-Fathi A, Yale JF, Bernier-Twardy S, Bossy A, Pytka E, Legault L, Haidar A
Steatotic Liver Disease, Fibrosis and Inflammatory Bowel Disease: Uncovering the Triple Threat
Principal investigators: Sebastiani, Giada; Bessissow, Talat; Betel, Michael; Saeed, Sahar Z; Swain, Mark G; Williams, Astrid-Jane
Keywords: Biobank; Biological Sex; Diabetes; Inflammatory Bowel Disease; Liver Fibrosis; Obesity; Patient Reported Outcomes; Risk Score; Steatotic Liver Disease
Comparative Efficacy and Safety of GLP-1 Receptor Agonists and Co-Agonists for Weight Loss Among Adults with Overweight or Obesity without Diabetes: A Systematic Review and Network Meta-Analysis
Principal investigators: Eisenberg, Mark J
Keywords: Glp-1 Receptor Agonists; Incretin Co-Agonists; Network Meta-Analysis; Obesity Pharmacotherapy; Systematic Review; Weight Management
Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program
Principal investigators: Sharma, Abhinav; Friedrich, Matthias G; Giannetti, Nadia; Mavrakanas, Thomas; Thanassoulis, George; Tsoukas, Michael A
Keywords: Cardia Magnetic Resonnance; Cardiovascular Outcomes; Clinical Clustering; Integrative Multi-Omics; Latent Class Analysis; Metabolomics/Lipidomics; Molecular Phenotyping; Precision Medicine; Proteomics; Type-2-Diabetes Heterogeneity
Delivering Evidence-Based Care Using Artificial Intelligence to Patients with Diabetes and CardioVascular Comorbidities: From Proof of Concept to Multi-Centre Expansion (DECIDE-CV-2)
Principal investigators: Sharma, Abhinav; Pilote, Louise
Keywords: Artificial Intelligence; Biomarker Validation; Diabetes Population Screening; Digital Biomarker; Digital Health; Early Diagnosis; Machine Learning; Multi-Center Study; Type-2 Diabetes; Wearable Device
Effects of GLP1-agonist induced weight loss on brain, metabolic, and cerebrovascular health measures.
Principal investigators: Dagher, Alain
Keywords: Brain Health; Cerebrovascular Disease; Dementia; Magnetic Resonance Imaging; Metabolic Syndrome; Neurodegeneration; Obesity
5th International Workshop of the Canadian NASH Network (CanNASH): "A Canadian multistakeholder approach to the holistic management of MASLD"
Principal investigators: Sebastiani, Giada; Betel, Michael; Patel, keyur; Ramji, Alnoor; Saeed, Sahar Z; Swain, Mark G
Keywords: Biological Sex; Diabetes; Hepatis Steatosis; Metabolic Syndrome; Obesity; Steatohepatitis
4th International Workshop of the Canadian NASH Network (CanNASH): "Towards a Canadian NASH Guidance"
Principal investigators: Sebastiani, Giada; Bajaj, Harpreet S; Betel, Michael; Patel, keyur; Ramji, Alnoor; Saeed, Sahar Z; Swain, Mark G
Keywords: Biological Sex; Diabetes; Fatty Liver; Metabolic Syndrome; Nonalcoholic Steatohepatitis; Obesity
Café Scientifique: Advances in Type 1 Diabetes
Principal investigators: Haidar, Ahmad
Keywords: Adjunctive Therapy; Continuous Subcutaneous Insulin Infusion; Insulin; Knowledge Dissemination; Multiple Daily Injections; Patient-Centered Approach; Type 1 Diabetes
Co-administration of pramlintide and insulin via an automated dual-hormone artificial pancreas system to regulate glucose levels in type 1 diabetes: a 4-week, outpatient, randomized, controlled, crossover trial
Principal investigators: Haidar, Ahmad
Keywords: Amylin; Artificial Pancreas Systems; Clinical Trial; Diabetes Technology; Glucose Sensors; Insulin Pump; Type 1 Diabetes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine/Cardiology
- Medicine
- Endocrinology
- Medicine/Nephrology
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Abhinav Sharma
Medicine/Cardiology
4 shared papers, latest 2024
Ahmad Haidar
Endocrinology
3 shared papers, latest 2026
Nadia Giannetti
Medicine/Cardiology
2 shared papers, latest 2022
Tricia Peters
Medicine
2 shared papers, latest 2022
Justin Ezekowitz
Medicine
2 shared papers, latest 2022
Thomas Mavrakanas
Medicine/Cardiology
1 shared papers, latest 2022
Rita Suri
Medicine
1 shared papers, latest 2022
Rita Suri
Medicine/Nephrology
1 shared papers, latest 2022
Laurent Legault
Faculty
1 shared papers, latest 2020
Laurent Legault
Faculty
1 shared papers, latest 2020
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.